During a panel discussion at MedCity News’ INVEST Digital Health conference in Dallas, three venture capital investors shared some of the questions they ask when getting pitched by digital health startups. The post 3 Questions VCs Ask When Getting Pitched By Startups appeared first on MedCity News.
The 32BJ Labor Industry Cooperation Fund recently unveiled two new tools for employers and unions: the Healthcare Savings Calculator and a model contract template. The post 32BJ Labor Industry Cooperation Fund Launches New Tools to Reduce Costs for Employers appeared first on MedCity News.
Dr. Cunningham weighed in on a variety of subjects, including elements of technology and virtual care that burden primary care physicians, as well as technologies that are suitable for remote monitoring of older patients. The post 7 Takeaways From a Fireside Chat with Providence’s Chief of Virtual Care appeared first on MedCity News.
MDMA-assisted therapy (MDMA-AT) for PTSD sparked debate, primarily focused on concerns of safety and efficacy. But no matter how novel a treatment may be, if it is inaccessible to the millions of people who need it, its relevance becomes insignificant. The post Breaking Barriers: Why Accessibility Matters in PTSD Treatment Beyond MDMA appeared first on…
The reintroduction of the “Improving Seniors’ Timely Access to Care Act” marks a critical step toward modernizing the prior authorization process within Medicare Advantage plans. So, what does this mean for patients and providers moving forward? The post Navigating the Government’s Medicare Advantage Prior Authorization Changes appeared first on MedCity News.
Insilico Medicine’s idiopathic pulmonary fibrosis drug led to dose-dependent improvement in lung function in a mid-stage study. Meanwhile, Pliant Therapeutics and PureTech Health are also making Phase 2 progress while Boehringer Ingelheim is planning regulatory submission supported by its IPF drug’s Phase 3 data. The post AI-Designed Insilico Drug Flashes Signs of Efficacy in Lung…
KFF Health News senior correspondent Aneri Pattani discussed opioid settlements and the Supreme Court’s overturning of a bankruptcy deal involving Purdue Pharma on the “Front Porch Book Club” podcast on Sept. 17. Pattani, joined by journalist Ed Mahon, also discussed how much opioid settlement money Pennsylvania is receiving, who makes the spending decisions, and how…
Meditech is integrating Suki’s AI assistant into more than a dozen rural health systems, including St. Mary’s Healthcare in New York and Decatur County Memorial Hospital in Indiana. The post When It Comes to AI, Rural Doctors Have FOMO — Meditech & Suki Are Teaming Up to Address This appeared first on MedCity News.
In two letters, U.S. representatives and senators called for an extension of the enhanced premium tax credits, which are set to expire in 2025 and have lowered costs for those purchasing coverage on the marketplace. The post 195 Congress Members Call for Extension of Enhanced Premium Tax Credits appeared first on MedCity News.
Zevra Therapeutics drug Miplyffa is now FDA approved for Niemann-Pick disease type C, a lysosomal storage disorder. The affirmative regulatory decision took into account additional clinical data generated since the FDA turned down a submission for the drug in 2021. The post FDA Approval Makes a Zevra Drug the First Therapy for Rare and Fatal…